Table 4.
National estimates of 1-year PSA screening rates by comorbidities, self-rated health, timed up and go test, and functional health
| Variables | Total (%) | PSA Screening Rates
|
||
|---|---|---|---|---|
| N=709 | (95% CI) | <1 yr | (95% CI) | |
| Comorbidity Index Score | ||||
| 0 | 19.2 | (16.3–22.1) | 50.1 | (39.0–61.1) |
| 1 | 23.4 | (20.2–26.6) | 62.8 | (55.5–69.5) |
| 2 | 21.9 | (18.5–25.3) | 58.7 | (48.9–67.9) |
| 3 | 12.3 | (9.1–15.6) | 60.2 | (46.5–72.4) |
| 4 | 9.5 | (6.9–12.1) | 63.1 | (47.9–76.0) |
| 5+ | 13.7 | (10.8–16.6) | 56.7 | (43.6–68.9) |
| Self-rated health | ||||
| Excellent | 14.1 | (11.2–16.9) | 54.1 | (43.3–64.6) |
| Very good | 29.6 | (26.4–32.8) | 67.0 | (58.7–74.3) |
| Good | 31.3 | (27.6–35.0) | 60.0 | (52.8–66.8) |
| Fair | 18.7 | (15.1–22.3) | 53.2 | (42.3–63.7) |
| Poor | 6.4 | (4.9–7.9) | 34.5 | (21.5–50.2) |
| TUG test time (seconds)1 | ||||
| 0–10 | 37.7 | (31.4–44.0) | 73.2 | (63.6–81.1) |
| 11–15 | 44.7 | (38.4–51.0) | 57.1 | (46.9–66.7) |
| 16+ | 17.7 | (12.3–23.0) | 38.6 | (27.4–51.3) |
| Functional Health | ||||
| Not impaired | 96.2 | (94.5–97.9) | 59.1 | (53.8–64.2) |
| Mobility impaired | 3.0 | (1.4–4.7) | 37.8 | (19.6–60.3) |
| ADL impaired | 0.8 | (0.3–1.4) | 41.1 | (17.5–69.7) |
1
Timed up and Go test only performed on n=327 subsample
Abbreviations: PSA - Prostate-specific antigen, TUG - Timed Up and Go test ADL - Activities of Daily Living, CI - confidence interval